DK0756596T3 - Tropan-2-aldoximderivater som neurotransmitter-genoptagelsesinhibitorer - Google Patents

Tropan-2-aldoximderivater som neurotransmitter-genoptagelsesinhibitorer

Info

Publication number
DK0756596T3
DK0756596T3 DK95915869T DK95915869T DK0756596T3 DK 0756596 T3 DK0756596 T3 DK 0756596T3 DK 95915869 T DK95915869 T DK 95915869T DK 95915869 T DK95915869 T DK 95915869T DK 0756596 T3 DK0756596 T3 DK 0756596T3
Authority
DK
Denmark
Prior art keywords
pct
reuptake inhibitors
tropan
date oct
neurotransmitter reuptake
Prior art date
Application number
DK95915869T
Other languages
Danish (da)
English (en)
Inventor
Peter Moldt
Frank Waetjen
Jorgen Scheel-Krueger
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Application granted granted Critical
Publication of DK0756596T3 publication Critical patent/DK0756596T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK95915869T 1994-04-19 1995-04-12 Tropan-2-aldoximderivater som neurotransmitter-genoptagelsesinhibitorer DK0756596T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK44794 1994-04-19
DK133894 1994-11-24
PCT/EP1995/001358 WO1995028401A1 (en) 1994-04-19 1995-04-12 Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors

Publications (1)

Publication Number Publication Date
DK0756596T3 true DK0756596T3 (da) 2002-12-23

Family

ID=26064021

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95915869T DK0756596T3 (da) 1994-04-19 1995-04-12 Tropan-2-aldoximderivater som neurotransmitter-genoptagelsesinhibitorer

Country Status (25)

Country Link
US (1) US5736556A (cs)
EP (1) EP0756596B1 (cs)
JP (1) JP2899418B2 (cs)
KR (1) KR100210417B1 (cs)
CN (1) CN1043763C (cs)
AT (1) ATE222587T1 (cs)
AU (1) AU690257B2 (cs)
BG (1) BG63259B1 (cs)
BR (1) BR9507489A (cs)
CA (1) CA2187309C (cs)
CZ (1) CZ284379B6 (cs)
DE (1) DE69527839T2 (cs)
DK (1) DK0756596T3 (cs)
EE (1) EE03877B1 (cs)
FI (1) FI965074A0 (cs)
GE (1) GEP19991749B (cs)
HU (1) HU215830B (cs)
LV (1) LV11738B (cs)
NO (1) NO964180L (cs)
NZ (1) NZ284075A (cs)
PL (1) PL183025B1 (cs)
RU (1) RU2134264C1 (cs)
SK (1) SK280875B6 (cs)
UA (1) UA49801C2 (cs)
WO (1) WO1995028401A1 (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69637097T2 (de) * 1995-10-13 2007-09-20 Neurosearch A/S 8-Azabicyclo(3.2.1)Oct-2-en-Derivate, deren Herstellung und Anwendung
US6241963B1 (en) * 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
SK282944B6 (sk) * 1995-11-02 2003-01-09 Neurosearch A/S Tavené tropánové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie
US5948933A (en) * 1997-07-11 1999-09-07 Organix, Inc. Tropane analogs and methods for inhibition of monoamine transport
DK0885220T3 (da) * 1996-02-22 2001-10-15 Neurosearch As Tropanderivater, deres fresmtilling og anvendelse
US6232326B1 (en) 1998-07-14 2001-05-15 Jodi A. Nelson Treatment for schizophrenia and other dopamine system dysfunctions
US20040229908A1 (en) * 1999-07-13 2004-11-18 Jodi Nelson Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias
WO2001003649A2 (en) 1999-07-13 2001-01-18 Alpha Research Group, Llc Compositions and methods for the treatment of parkinson's disease
DE60135685D1 (de) * 2000-05-26 2008-10-16 Pfizer Triazolyltropanderivate als ccr5-modulatoren
US6667314B2 (en) 2000-05-26 2003-12-23 Pfizer, Inc. Tropane derivatives useful in therapy
US20040106643A1 (en) * 2001-05-23 2004-06-03 Gouliaev Alex Haarh Tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US6610849B2 (en) * 2001-06-28 2003-08-26 Boehringer Ingelheim Pharma Kg Process for the manufacture of tropenol
EP1453511B1 (en) * 2001-11-30 2006-11-15 Neurosearch A/S Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
CA2480742A1 (en) * 2002-03-28 2003-12-04 President And Fellows Of Harvard College Tropane compounds
MXPA06003749A (es) 2003-10-03 2006-06-14 Pfizer Derivados de tropano.
EP1675591B1 (en) * 2003-10-16 2011-08-10 NeuroSearch A/S Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor
WO2005070429A1 (en) * 2004-01-22 2005-08-04 Neurosearch A/S Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist
JP2007519646A (ja) * 2004-01-22 2007-07-19 ノイロサーチ アクティーゼルスカブ 体重の持続的低減のための化合物
RU2352332C1 (ru) * 2005-01-14 2009-04-20 Частное Предприятие "Славянская Клиника" Применение местного анестетика для коррекции пищевого поведения человека и способ применения
EP1779851A1 (en) 2005-10-31 2007-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Treatment of diabetes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3813404A (en) * 1972-11-15 1974-05-28 Sterling Drug Inc Tropane-2-carboxylates and derivatives
SU941369A1 (ru) * 1978-12-29 1982-07-07 Научно-исследовательский институт фармакологии АМН СССР Хлоргидраты W-аминоацильных эфиров тропан-3-ола как стимул торы центральной нервной системы
AT397962B (de) * 1985-12-27 1994-08-25 Madaus & Co Dr Verfahren zur herstellung von azoniaspironortropanolestern
AU671163B2 (en) * 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds
AU672052B2 (en) * 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds

Also Published As

Publication number Publication date
HUT75865A (en) 1997-05-28
PL183025B1 (pl) 2002-05-31
LV11738A (lv) 1997-04-20
DE69527839D1 (en) 2002-09-26
EP0756596B1 (en) 2002-08-21
JP2899418B2 (ja) 1999-06-02
EE03877B1 (et) 2002-10-15
EE9600132A (et) 1997-04-15
EP0756596A1 (en) 1997-02-05
CN1148854A (zh) 1997-04-30
BG100883A (en) 1998-03-31
UA49801C2 (uk) 2002-10-15
GEP19991749B (en) 1999-09-10
CN1043763C (zh) 1999-06-23
CZ298296A3 (en) 1997-06-11
NZ284075A (en) 1998-01-26
AU690257B2 (en) 1998-04-23
LV11738B (en) 1997-12-20
SK128896A3 (en) 1997-04-09
WO1995028401A1 (en) 1995-10-26
CA2187309A1 (en) 1995-10-26
RU2134264C1 (ru) 1999-08-10
HU9602707D0 (en) 1996-11-28
MX9604966A (es) 1998-05-31
NO964180D0 (no) 1996-10-02
JPH09505607A (ja) 1997-06-03
FI965074A7 (fi) 1996-12-17
AU2257595A (en) 1995-11-10
BR9507489A (pt) 1997-08-12
DE69527839T2 (de) 2003-01-02
FI965074A0 (fi) 1996-12-17
CA2187309C (en) 2000-11-21
PL316876A1 (en) 1997-02-17
BG63259B1 (bg) 2001-07-31
SK280875B6 (sk) 2000-08-14
HU215830B (hu) 2001-05-28
KR100210417B1 (ko) 1999-07-15
US5736556A (en) 1998-04-07
ATE222587T1 (de) 2002-09-15
NO964180L (no) 1996-12-16
CZ284379B6 (cs) 1998-11-11

Similar Documents

Publication Publication Date Title
DK0756596T3 (da) Tropan-2-aldoximderivater som neurotransmitter-genoptagelsesinhibitorer
BR9610960A (pt) Derivados de 8-azabiciclo [3.2.1] oct -2- eno sua preparação e uso
CA2244773A1 (en) Tropane-derivatives, their preparation and use
IL110494A0 (en) Perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them
IL151172A0 (en) Amine derivatives, their preparation and use as bax modulators
BR9611175B1 (pt) compostos e composiÇÕes farmacÊuticas.
HUT77925A (hu) Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukra
DE69313051D1 (de) Ethanolamin-derivate mit sympathomimetischer und anti-pollakiuria wirkung
HRP20050213A2 (en) 2,4-substituted indoles and their use as 5-ht6 modulators
HUT77768A (hu) N-szubsztituált azabicikloheptánszármazékok, eljárás előállításukra és alkalmazásuk
CA2112061A1 (en) Alkyl substituted heterocyclic compounds
BR9607841A (pt) Método para a preparação de estéres de anidroeggonina